Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Impact of target joint and FVIII inhibitor οn bone properties in children with haemophilia A: A peripheral quantitative computed tomography study.

Xafaki P, Balanika A, Pergantou H, Papakonstantinou O, Platokouki H.

Haemophilia. 2018 Sep;24(5):800-806. doi: 10.1111/hae.13591. Epub 2018 Aug 8.

PMID:
30088693
2.

Desmopressin in moderate hemophilia A patients: a treatment worth considering.

Loomans JI, Kruip MJHA, Carcao M, Jackson S, van Velzen AS, Peters M, Santagostino E, Platokouki H, Beckers E, Voorberg J, van der Bom JG, Fijnvandraat K; RISE consortium.

Haematologica. 2018 Mar;103(3):550-557. doi: 10.3324/haematol.2017.180059. Epub 2018 Jan 5.

3.

Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.

Platokouki H, Fischer K, Gouw SC, Rafowicz A, Carcao M, Kenet G, Liesner R, Kurnik K, Rivard GE, van den Berg HM.

Haemophilia. 2018 Mar;24(2):283-290. doi: 10.1111/hae.13387. Epub 2017 Dec 15.

PMID:
29243367
4.

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.

Mancuso ME, Fischer K, Santagostino E, Oldenburg J, Platokouki H, Königs C, Escuriola-Ettingshausen C, Rivard GE, Cid AR, Carcao M, Ljung R, Petrini P, Altisent C, Kenet G, Liesner R, Kurnik K, Auerswald G, Chambost H, Mäkipernaa A, Molinari AC, Williams M, van den Berg HM; European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group.

Thromb Haemost. 2017 Dec;117(12):2274-2282. doi: 10.1160/TH17-01-0059. Epub 2017 Dec 6.

PMID:
29212115
5.

Tracheal stenosis in a paediatric patient with severe haemophilia A and FVIII inhibitors.

Pergantou H, Zachou Z, Vachlas K, Dettoraki A, Lykopoulou L, Parpounas K, Platokouki H.

Haemophilia. 2017 Nov;23(6):e523-e525. doi: 10.1111/hae.13346. Epub 2017 Sep 19. No abstract available.

PMID:
28925572
6.

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment.

Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, Hoffmann M, Kavakli K, Kenet G, Kobelt R, Kurnik K, Liesner R, Mäkipernaa A, Manco-Johnson MJ, Mancuso ME, Molinari AC, Nolan B, Perez Garrido R, Petrini P, Platokouki HE, Shapiro AD, Wu R, Ljung R.

Br J Haematol. 2017 Oct;179(2):298-307. doi: 10.1111/bjh.14844. Epub 2017 Jul 12.

PMID:
28699675
7.

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

Nijdam A, Altisent C, Carcao MD, Cid AR, Claeyssens-Donadel S, Kurnik K, Ljung R, Nolan B, Petrini P, Platokouki H, Rafowicz A, Thomas AE, Fischer K; PedNet and CANAL study groups.

Haematologica. 2015 Mar;100(3):e84-6. doi: 10.3324/haematol.2014.115709. Epub 2014 Dec 19. No abstract available.

8.

Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia A.

Meijer K, Rauchensteiner S, Santagostino E, Platokouki H, Schutgens RE, Brunn M, Tueckmantel C, Valeri F, Schinco PC.

Haemophilia. 2015 Jan;21(1):e19-25. doi: 10.1111/hae.12530. Epub 2014 Dec 2.

PMID:
25458982
9.

Cochlear implantation is safe and effective in patients with MYH9-related disease.

Pecci A, Verver EJ, Schlegel N, Canzi P, Boccio CM, Platokouki H, Krause E, Benazzo M, Topsakal V, Greinacher A.

Orphanet J Rare Dis. 2014 Jun 30;9:100. doi: 10.1186/1750-1172-9-100.

10.

Spectrum of the mutations in Bernard-Soulier syndrome.

Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, Caliskan U, Tokgoz H, Pecci A, Noris P, Srivastava A, Ward C, Morel-Kopp MC, Alessi MC, Bellucci S, Beurrier P, de Maistre E, Favier R, Hézard N, Hurtaud-Roux MF, Latger-Cannard V, Lavenu-Bombled C, Proulle V, Meunier S, Négrier C, Nurden A, Randrianaivo H, Fabris F, Platokouki H, Rosenberg N, HadjKacem B, Heller PG, Karimi M, Balduini CL, Pastore A, Lanza F.

Hum Mutat. 2014 Sep;35(9):1033-45. doi: 10.1002/humu.22607. Epub 2014 Jul 15. Review.

PMID:
24934643
11.

Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry.

Fischer K, Ljung R, Platokouki H, Liesner R, Claeyssens S, Smink E, van den Berg HM.

Haemophilia. 2014 Jul;20(4):e280-6. doi: 10.1111/hae.12448. Epub 2014 May 2.

PMID:
24784937
12.

Venous thromboembolism at uncommon sites in neonates and children.

Pergantou H, Avgeri M, Komitopoulou A, Xafaki P, Kapsimali Z, Mazarakis M, Adamtziki E, Platokouki H.

J Pediatr Hematol Oncol. 2014 Nov;36(8):624-9. doi: 10.1097/MPH.0000000000000116.

PMID:
24517966
13.

MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.

Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, Russo G, Heller PG, Loffredo G, Ballmaier M, Fabris F, Beggiato E, Kahr WH, Pujol-Moix N, Platokouki H, Van Geet C, Noris P, Yerram P, Hermans C, Gerber B, Economou M, De Groot M, Zieger B, De Candia E, Fraticelli V, Kersseboom R, Piccoli GB, Zimmermann S, Fierro T, Glembotsky AC, Vianello F, Zaninetti C, Nicchia E, Güthner C, Baronci C, Seri M, Knight PJ, Balduini CL, Savoia A.

Hum Mutat. 2014 Feb;35(2):236-47. doi: 10.1002/humu.22476. Epub 2013 Dec 12.

14.

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

Eckhardt CL, van Velzen AS, Peters M, Astermark J, Brons PP, Castaman G, Cnossen MH, Dors N, Escuriola-Ettingshausen C, Hamulyak K, Hart DP, Hay CR, Haya S, van Heerde WL, Hermans C, Holmström M, Jimenez-Yuste V, Keenan RD, Klamroth R, Laros-van Gorkom BA, Leebeek FW, Liesner R, Mäkipernaa A, Male C, Mauser-Bunschoten E, Mazzucconi MG, McRae S, Meijer K, Mitchell M, Morfini M, Nijziel M, Oldenburg J, Peerlinck K, Petrini P, Platokouki H, Reitter-Pfoertner SE, Santagostino E, Schinco P, Smiers FJ, Siegmund B, Tagliaferri A, Yee TT, Kamphuisen PW, van der Bom JG, Fijnvandraat K; INSIGHT Study Group.

Blood. 2013 Sep 12;122(11):1954-62. doi: 10.1182/blood-2013-02-483263. Epub 2013 Aug 7. Erratum in: Blood. 2014 May 8;123(19):3056.

15.

Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A.

Pergantou H, Varela I, Moraloglou O, Economou M, Spanou K, Kapsimali Z, Constantinidou N, Platokouki H.

Haemophilia. 2013 Sep;19(5):706-10. doi: 10.1111/hae.12168. Epub 2013 Apr 22.

PMID:
23607306
16.

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.

Gouw SC, van den Berg HM, Fischer K, Auerswald G, Carcao M, Chalmers E, Chambost H, Kurnik K, Liesner R, Petrini P, Platokouki H, Altisent C, Oldenburg J, Nolan B, Garrido RP, Mancuso ME, Rafowicz A, Williams M, Clausen N, Middelburg RA, Ljung R, van der Bom JG; PedNet and Research of Determinants of INhibitor development (RODIN) Study Group.

Blood. 2013 May 16;121(20):4046-55. doi: 10.1182/blood-2012-09-457036. Epub 2013 Apr 3.

17.

Deep vein thrombosis and pulmonary embolism in a child with diabetic ketoacidosis and protein s deficiency: a case report.

Sdogou T, Kossiva L, Kakleas K, Platokouki H, Tentolouri T, Georgouli H, Karayianni C, Karavanaki K.

Horm Res Paediatr. 2013;79(2):114-8. doi: 10.1159/000343813. Epub 2013 Jan 10.

PMID:
23306559
18.

Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.

Mariani G, Napolitano M, Dolce A, Pérez Garrido R, Batorova A, Karimi M, Platokouki H, Auerswald G, Bertrand AM, Di Minno G, Schved JF, Bjerre J, Ingerslev J, Sørensen B, Ruiz-Saez A; Seven Treatment Evaluation Registry; International Factor VII Deficiency Study Group.

Thromb Haemost. 2013 Feb;109(2):238-47. doi: 10.1160/TH12-07-0476. Epub 2012 Dec 13.

PMID:
23238632
19.

MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.

De Rocco D, Zieger B, Platokouki H, Heller PG, Pastore A, Bottega R, Noris P, Barozzi S, Glembotsky AC, Pergantou H, Balduini CL, Savoia A, Pecci A.

Eur J Med Genet. 2013 Jan;56(1):7-12. doi: 10.1016/j.ejmg.2012.10.009. Epub 2012 Oct 30.

20.

The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor.

Pergantou H, Xafaki P, Adamtziki E, Koletsi P, Komitopoulou A, Platokouki H.

Haemophilia. 2012 May;18(3):e66-7. doi: 10.1111/j.1365-2516.2012.02799.x. No abstract available.

PMID:
22531022
21.

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.

Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, Pergantou H, Platokouki H, Giangrande P, Peerlinck K, Celkan T, Ozdemir N, Bidlingmaier C, Ingerslev J, Giansily-Blaizot M, Schved JF, Gilmore R, Gadisseur A, Benedik-Dolničar M, Kitanovski L, Mikovic D, Musallam KM, Rosendaal FR; European Network of Rare Bleeding Disorders Group.

J Thromb Haemost. 2012 Apr;10(4):615-21. doi: 10.1111/j.1538-7836.2012.04653.x.

22.

Two de novo factor VIII gene mutations in the family of an isolated severe haemophilia A patient.

Kapsimali Z, Pavlova A, Pergantou H, Adamtziki E, Oldenburg J, Platokouki H.

Haemophilia. 2012 Jan;18(1):e3-4. doi: 10.1111/j.1365-2516.2011.02609.x. Epub 2011 Jul 11. No abstract available.

PMID:
21740484
23.

Management of ligneous conjunctivitis in a child with plasminogen deficiency.

Pergantou H, Likaki D, Fotopoulou M, Katsarou O, Xafaki P, Platokouki H.

Eur J Pediatr. 2011 Oct;170(10):1333-6. doi: 10.1007/s00431-011-1483-9. Epub 2011 May 31.

PMID:
21625933
24.

Osteoid osteoma in a child with severe von Willebrand disease.

Petratos D, Matsinos G, Pergantou H, Anastasopoulos J, Platokouki H.

Haemophilia. 2010 May;16(3):557-9. doi: 10.1111/j.1365-2516.2009.02148.x. Epub 2009 Nov 23. No abstract available.

PMID:
19930471
25.

Assessment of the progression of haemophilic arthropathy in children.

Pergantou H, Platokouki H, Matsinos G, Papakonstantinou O, Papadopoulos A, Xafaki P, Petratos D, Aronis S.

Haemophilia. 2010 Jan;16(1):124-9. doi: 10.1111/j.1365-2516.2009.02109.x. Epub 2009 Sep 9.

PMID:
19744251
26.

Intraosseous pseudotumour of the talus in a child with severe haemophilia.

Petratos DV, Pergantou H, Matsinos GS, Anastasopoulos JN, Platokouki H.

J Pediatr Orthop B. 2009 Nov;18(6):357-61. doi: 10.1097/BPB.0b013e32832f07d4.

PMID:
19593217
27.

An attempt to improve the clinical scale for assessment of haemophilic arthropathy in children.

Pergantou H, Matsinos G, Platokouki H, Papadopoulos A, Aronis S.

J Pediatr Orthop B. 2009 Jul;18(4):204-10. doi: 10.1097/BPB.0b013e32832bf5ad.

PMID:
19458553
28.

Immune tolerance induction with high von Willebrand factor/factor VIII content ratio concentrate in children with haemophilia A and high-responding inhibitor.

Platokouki H, Pergantou H, Xafaki P, Komitopoulou A, Aronis S.

Haemophilia. 2009 Mar;15(2):617-9. doi: 10.1111/j.1365-2516.2008.01965.x. Epub 2009 Jan 20. No abstract available.

PMID:
19175417
29.

Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.

Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S.

J Pediatr Hematol Oncol. 2008 Aug;30(8):592-7. doi: 10.1097/MPH.0b013e31817541a8.

PMID:
18799935
30.

Recurrent idiopathic thrombocytopenic purpura in childhood.

Vranou M, Platokouki H, Pergantou H, Aronis S.

Pediatr Blood Cancer. 2008 Aug;51(2):261-4. doi: 10.1002/pbc.21569.

PMID:
18421719
31.

Mutations and polymorphisms in genes affecting haemostasis components in children with thromboembolic events.

Komitopoulou A, Platokouki H, Kapsimali Z, Moschovi M, Kattamis A, Pergantou H, Aronis S.

Pathophysiol Haemost Thromb. 2006;35(5):392-7.

PMID:
17230042
32.

Comparative study of validity of clinical, X-ray and magnetic resonance imaging scores in evaluation and management of haemophilic arthropathy in children.

Pergantou H, Matsinos G, Papadopoulos A, Platokouki H, Aronis S.

Haemophilia. 2006 May;12(3):241-7.

PMID:
16643208
33.

Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke.

Komitopoulou A, Platokouki H, Kapsimali Z, Pergantou H, Adamtziki E, Aronis S.

Cerebrovasc Dis. 2006;22(1):13-20. Epub 2006 Mar 27.

PMID:
16567932
34.

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

Moschovi M, Aronis S, Trimis G, Platokouki H, Salavoura K, Tzortzatou-Stathopoulou F.

Haemophilia. 2006 Jan;12(1):95-9.

PMID:
16409183
35.

Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.

Moschovi M, Trimis G, Pergantou H, Platokouki H, Vrachnou E, Tzortzatou-Stathopoulou F.

J Paediatr Child Health. 2005 Jul;41(7):384-6.

PMID:
16014149
36.

Retrospective evaluation of long-term efficacy and safety of splenectomy in chronic idiopathic thrombocytopenic purpura in children.

Aronis S, Platokouki H, Avgeri M, Pergantou H, Keramidas D.

Acta Paediatr. 2004 May;93(5):638-42.

PMID:
15174787
37.

Prothrombotic factors in neonates with cerebral thrombosis and intraventricular hemorrhage.

Aronis S, Bouza H, Pergantou H, Kapsimalis Z, Platokouki H, Xanthou M.

Acta Paediatr Suppl. 2002;91(438):87-91.

PMID:
12477269
38.

Diffuse splenic and visceral hemangiomas complicated by chronic consumption coagulopathy.

Platokouki H, Aronis S, Mitsika A, Keramidas D, Harokopos E.

Acta Paediatr Jpn. 1998 Aug;40(4):381-4.

PMID:
9745787
39.

Indications of coagulation and/or fibrinolytic system activation in healthy and sick very-low-birth-weight neonates.

Aronis S, Platokouki H, Photopoulos S, Adamtziki E, Xanthou M.

Biol Neonate. 1998 Nov;74(5):337-44.

PMID:
9742262
40.

Haemostatic variables in phenylketonuric children under dietary treatment.

Schulpis KH, Platokouki H, Papakonstantinou ED, Adamtziki E, Bargeliotis A, Aronis S.

J Inherit Metab Dis. 1996;19(5):603-9.

PMID:
8892015
41.

Prevalence of inhibitor formation in a cohort of haemophilic children exposed to several products of various purities.

Aronis S, Platokouki H, Kapsimali Z, Adamtziki E, Kolokithas A, Mitsika A.

Haemophilia. 1995 Oct;1(4):236-42. doi: 10.1111/j.1365-2516.1995.tb00082.x.

PMID:
27214630
42.

Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better?

Aronis S, Platokouki H, Mitsika A, Haidas S, Constantopoulos A.

Pediatr Hematol Oncol. 1994 Sep-Oct;11(5):487-98.

PMID:
7826845
43.

Subclinical neuropathy in children with inherited haemostasis disorders.

Stamboulis EJ, Syrigou-Papavasiliou A, Platokouki HG, Mitsika AP, Aronis SA.

Electromyogr Clin Neurophysiol. 1992 Oct-Nov;32(10-11):511-4.

PMID:
1446583

Supplemental Content

Loading ...
Support Center